Glory Pharmachem India Profile
Key Indicators
- Authorised Capital ₹ 9.20 Cr
as on 17-07-2024
- Paid Up Capital ₹ 9.10 Cr
as on 17-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.84 M
as on 17-07-2024
- Satisfied Charges ₹ 3.60 Cr
as on 17-07-2024
- Revenue 50.15%
(FY 2022)
- Profit 331.33%
(FY 2022)
- Ebitda 176.38%
(FY 2022)
- Net Worth 31.02%
(FY 2022)
- Total Assets 6.59%
(FY 2022)
About Glory Pharmachem India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.20 Cr and a paid-up capital of Rs 9.10 Cr.
The company currently has active open charges totaling ₹9.84 M. The company has closed loans amounting to ₹3.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raghuveer Beti and Ramachandra Gongati serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC053462
- Company No.
053462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Glory Pharmachem India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramachandra Gongati  | Director | 27-Sep-2018 | Current |
| Raghuveer Beti | Director | 03-Feb-2017 | Current |
Financial Performance and Corporate Structure Insights of Glory Pharmachem India.
Glory Pharmachem India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.15% increase. The company also saw a substantial improvement in profitability, with a 331.33% increase in profit. The company's net worth Soared by an impressive increase of 31.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glory Pharmachem India?
In 2022, Glory Pharmachem India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Tirupati Research & Development Private LimitedActive 1 year 4 months
Ramachandra Gongati is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jul 2018 | ₹0.84 M | Open |
Andhra Pradesh State Financial Corporation Creation Date: 18 Oct 2011 | ₹9.00 M | Open |
Andhra Pradesh State Financial Corporation Creation Date: 02 Jun 2015 | ₹4.00 M | Satisfied |
How Many Employees Work at Glory Pharmachem India?
Glory Pharmachem India has a workforce of 4 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glory Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glory Pharmachem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
